AMPH
Amphastar Pharmaceuticals, Inc.Company with tickers: AMPH
CIK
1297184
CUSIP
03209R103
Shares Outstanding
44,092,919
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $171,171,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | $100,849,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Gross Profit | $70,322,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Expenses | $56,692,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $26,737,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $13,630,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $6,420,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $0.14 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $0.14 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |